Pharmacological interventions lower blood pressure (BP) by inhibiting the renin-angiotensin-aldosterone system (RAAS), such as angiotensin-converting enzyme (ACE) inhibitors, have long been proven effective in clinical and experimental settings for the treatment of hypertension and HF (11, 12). The gene discussed is ACE; the disease is Hypertension.